Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma.

MLA

Smith, Jasmine, et al. “Concurrent Application of Blinatumomab and Haploidentical Donor Leukocyte Infusions for Refractory Primary Mediastinal Large B-Cell Lymphoma.” Therapeutic Advances in Hematology, vol. 12, Feb. 2021, p. 2040620721994348. EBSCOhost, https://doi.org/10.1177/2040620721994348.

APA

Smith, J., Kumar, A., Stanton, N. A., & Katsanis, E. (2021). Concurrent application of blinatumomab and haploidentical donor leukocyte infusions for refractory primary mediastinal large B-cell lymphoma. Therapeutic Advances in Hematology, 12, 2040620721994348. https://doi.org/10.1177/2040620721994348

Chicago

Smith, Jasmine, Abhijeet Kumar, Natalie A Stanton, and Emmanuel Katsanis. 2021. “Concurrent Application of Blinatumomab and Haploidentical Donor Leukocyte Infusions for Refractory Primary Mediastinal Large B-Cell Lymphoma.” Therapeutic Advances in Hematology 12 (February): 2040620721994348. doi:10.1177/2040620721994348.